Invasive insects, like this emerald ash borer, have destroyed tens of millions of trees in the United States. In a piece for the Washington Post, I track the bugs and call into question USDA regulations meant to stem the tide of tiny invaders.
Call it the brain fixer: A potent growth factor that could reverse stroke, interrupt addiction, and halt Parkinson’s disease. But getting it into the brain has proved challenging. In this feature for Nature, I explore new technology for sneaking this growth factor, GDNF, into the brain.
My profile of a young scientific superstar, Jonathan Abraham, appears in the August HHMI Bulletin. Abraham tackles a deadly, emerging South American virus, machupo.
I recently attended psychedelic medicine’s coming out party- a meeting of 1100 researchers and enthusiasts in San Jose, Calif. – and found the early data on MDMA (‘Ecstasy’) as an adjunct to talk therapy for post-traumatic stress disorder pretty compelling. Scientific American ran my piece on the study, which features a vet who says the therapy eliminated his PTSD symptoms.
- Ghostwriting “The Great Prostate Mistake”
- The Melting Snows of Kilimanjaro
- Drug Companies Used Physician Education to Push Pills
- Injections of Hope – Doctors Promote Offshore Shots but Some Patients Cry Foul
- A User-Friendly Computer Virus
- HIV Vaccine Efforts Inch Forward
- At the Cloning Circus, Sideshows Abound
- I’m moving…
- Another BBC Appearance
- Live Radio – BBC World Service
- From Trial to Mastery: A Guide for Educators Transitioning to Advanced Monitoring